Common Sleep Disorders in Pregnancy.
Journal
Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
received:
19
01
2022
accepted:
28
04
2022
entrez:
19
7
2022
pubmed:
20
7
2022
medline:
22
7
2022
Statut:
ppublish
Résumé
Compared with men, women have a greater risk of sleep disorders and report higher rates of sleep disturbance. Hormonal and physiologic changes throughout the life span appear to influence a woman's ability to get a good night's sleep. Sleep disturbances are commonly reported during pregnancy, affecting more than one-half of all pregnancies and increasing as gestation progresses. The pervasiveness of sleep complaints during pregnancy may lead to a belief that these symptoms are normal or to be expected. Unfortunately, this perception may impede the accurate diagnosis of sleep disorders during this crucial time. Obstructive sleep apnea, insomnia, and restless legs syndrome are the most common sleep disorders in pregnancy. Sleep disruption in pregnancy can substantially worsen maternal quality of life and may be a risk factor for adverse pregnancy outcomes. This review outlines important considerations for obstetricians taking care of pregnant patients with sleep-related complaints.
Identifiants
pubmed: 35852285
doi: 10.1097/AOG.0000000000004866
pii: 00006250-202208000-00027
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
321-339Informations de copyright
Copyright © 2022 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Financial Disclosure Francesca L. Facco disclosed receiving consulting fees from Bayer Pharmaceuticals and has received grant support through his institution from Bayer Pharmaceuticals, Philips Respironics, Respicardia and Sommetrics. Sanjay R. Patel disclosed that they and their institution received payment from Bayer Pharmaceuticals and Respicardia. They have an ongoing relationship with Philips Respironics resulting in payments made to their institution, and a current relationship with Sommetrics resulting in payments made to their institution. Sanjay R. Patel disclosed that this manuscript discusses off-label use of carbidopa/levodopa for restless legs syndrome. Megan Chan did not report any potential conflicts of interest.
Références
2007 Sleep in America Poll—women and sleep. Sleep Health 2015;1:e6. doi: 10.1016/j.sleh.2015.04.006.
doi: 10.1016/j.sleh.2015.04.006
International classification of sleep disorders. 3rd ed. American Academy of Sleep Medicine; 2014.
U.S. Food and Drug Administration. Pregnancy and lactation labeling (drugs) final rule. Accessed May 1, 2022. https://www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-drugs-final-rule
Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012;8:597–619. doi: 10.5664/jcsm.2172
doi: 10.5664/jcsm.2172
Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008;5:136–43. doi: 10.1513/pats.200709-155MG
doi: 10.1513/pats.200709-155MG
Dempsey JA, Skatrud JB, Jacques AJ, Ewanowski SJ, Woodson BT, Hanson PR, et al. Anatomic determinants of sleep-disordered breathing across the spectrum of clinical and nonclinical male subjects. Chest 2002;122:840–51. doi: 10.1378/chest.122.3.840
doi: 10.1378/chest.122.3.840
Meurling IJ, Shea DO, Garvey JF. Obesity and sleep: a growing concern. Curr Opin Pulm Med 2019;25:602–8. doi: 10.1097/MCP.0000000000000627
doi: 10.1097/MCP.0000000000000627
Lopez PP, Stefan B, Schulman CI, Byers PM. Prevalence of sleep apnea in morbidly obese patients who presented for weight loss surgery evaluation: more evidence for routine screening for obstructive sleep apnea before weight loss surgery. Am Surg 2008;74:834–8.
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006–14. doi: 10.1093/aje/kws342
doi: 10.1093/aje/kws342
Partinen M, Telakivi T. Epidemiology of obstructive sleep apnea syndrome. Sleep 1992;15:S1–4. doi: 10.1093/sleep/15.suppl_6.s1
doi: 10.1093/sleep/15.suppl_6.s1
Facco FL, Kramer J, Ho KH, Zee PC, Grobman WA. Sleep disturbances in pregnancy. Obstet Gynecol 2010;115:77–83. doi: 10.1097/AOG.0b013e3181c4f8ec
doi: 10.1097/AOG.0b013e3181c4f8ec
O'Brien LM, Bullough AS, Owusu JT, Tremblay KA, Brincat CA, Chames MC, et al. Pregnancy-onset habitual snoring, gestational hypertension, and preeclampsia: prospective cohort study. Am J Obstet Gynecol 2012;207:487.e1–9. doi: 10.1016/j.ajog.2012.08.034
doi: 10.1016/j.ajog.2012.08.034
Sarberg M, Svanborg E, Wirehn AB, Josefsson A. Snoring during pregnancy and its relation to sleepiness and pregnancy outcome - a prospective study. BMC Pregnancy Childbirth 2014;14:15. doi: 10.1186/1471-2393-14-15
doi: 10.1186/1471-2393-14-15
Oyiengo D, Louis M, Hott B, Bourjeily G. Sleep disorders in pregnancy. Clin Chest Med 2014;35:571–87. doi: 10.1016/j.ccm.2014.06.012
doi: 10.1016/j.ccm.2014.06.012
Pien GW, Pack AI, Jackson N, Maislin G, Macones GA, Schwab RJ. Risk factors for sleep-disordered breathing in pregnancy. Thorax 2014;69:371–7. doi: 10.1136/thoraxjnl-2012-202718
doi: 10.1136/thoraxjnl-2012-202718
Facco FL, Parker CB, Reddy UM, Silver RM, Koch MA, Louis JM, et al. Association between sleep-disordered breathing and hypertensive disorders of pregnancy and gestational diabetes mellitus. Obstet Gynecol 2017;129:31–41. doi: 10.1097/AOG.0000000000001805
doi: 10.1097/AOG.0000000000001805
Facco FL, Parker CB, Reddy UM, Silver RM, Louis JM, Basner RC, et al. NuMoM2b Sleep-Disordered Breathing study: objectives and methods. Am J Obstet Gynecol 2015;212:542.e1–127. doi: 10.1016/j.ajog.2015.01.021
doi: 10.1016/j.ajog.2015.01.021
Louis JM, Koch MA, Reddy UM, Silver RM, Parker CB, Facco FL, et al. Predictors of sleep-disordered breathing in pregnancy. Am J Obstet Gynecol 2018;218:521.e1–12. doi: 10.1016/j.ajog.2018.01.031
doi: 10.1016/j.ajog.2018.01.031
Facco FL, Ouyang DW, Zee PC, Grobman WA. Sleep disordered breathing in a high-risk cohort prevalence and severity across pregnancy. Am J Perinatol 2014;31:899–904. doi: 10.1055/s-0033-1363768
doi: 10.1055/s-0033-1363768
Kuvat N, Tanriverdi H, Armutcu F. The relationship between obstructive sleep apnea syndrome and obesity: a new perspective on the pathogenesis in terms of organ crosstalk. Clin Respir J 2020;14:595–604. doi: 10.1111/crj.13175
doi: 10.1111/crj.13175
Romero R, Badr MS. A role for sleep disorders in pregnancy complications: challenges and opportunities. Am J Obstet Gynecol 2014;210:3–11. doi: 10.1016/j.ajog.2013.11.020
doi: 10.1016/j.ajog.2013.11.020
Liu L, Su G, Wang S, Zhu B. The prevalence of obstructive sleep apnea and its association with pregnancy-related health outcomes: a systematic review and meta-analysis. Sleep Breath 2019;23:399–412. doi: 10.1007/s11325-018-1714-7
doi: 10.1007/s11325-018-1714-7
Hawkins M, Parker CB, Redline S, Larkin JC, Zee PP, Grobman WA, et al. Objectively assessed sleep-disordered breathing during pregnancy and infant birthweight. Sleep Med 2021;81:312–8. doi: 10.1016/j.sleep.2021.02.043
doi: 10.1016/j.sleep.2021.02.043
Louis JM, Auckley D, Sokol RJ, Mercer BM. Maternal and neonatal morbidities associated with obstructive sleep apnea complicating pregnancy. Am J Obstet Gynecol 2010;202:261.e1–5. doi: 10.1016/j.ajog.2009.10.867
doi: 10.1016/j.ajog.2009.10.867
Felder JN, Baer RJ, Rand L, Jelliffe-Pawlowski LL, Prather AA. Sleep disorder diagnosis during pregnancy and risk of preterm birth. Obstet Gynecol 2017;130:573–81. doi: 10.1097/AOG.0000000000002132
doi: 10.1097/AOG.0000000000002132
Louis JM, Mogos MF, Salemi JL, Redline S, Salihu HM. Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998-2009. Sleep 2014;37:843–9. doi: 10.5665/sleep.3644
doi: 10.5665/sleep.3644
Facco FL, LouisJ Knavert MP, Izci Balserak B. Sleep-disordered breathing in pregnancy. In: Kryger M, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 6th ed. Elsevier; 2017.
Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2017;13:479–504. doi: 10.5664/jcsm.6506
doi: 10.5664/jcsm.6506
Keshavarzi F, Mehdizadeh S, Khazaie H, Ghadami MR. Objective assessment of obstructive sleep apnea in normal pregnant and preeclamptic women. Hypertens Pregnancy 2018;37:154–9. doi: 10.1080/10641955.2018.1498879
doi: 10.1080/10641955.2018.1498879
Facco FL, Lopata V, Wolsk JM, Patel S, Wisniewski SR. Can we use home sleep testing for the evaluation of sleep apnea in obese pregnant women? Sleep Disord 2019;2019:3827579. doi: 10.1155/2019/3827579
doi: 10.1155/2019/3827579
Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007;3:737–47.
Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet 2014;383:736–47. doi: 10.1016/S0140-6736(13)60734-5
doi: 10.1016/S0140-6736(13)60734-5
Weaver TE, Mancini C, Maislin G, Cater J, Staley B, Landis JR, et al. Continuous positive airway pressure treatment of sleepy patients with milder obstructive sleep apnea: results of the CPAP Apnea Trial North American Program (CATNAP) randomized clinical trial. Am J Respir Crit Care Med 2012;186:677–83. doi: 10.1164/rccm.201202-0200OC
doi: 10.1164/rccm.201202-0200OC
Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100–5. doi: 10.1016/S0140-6736(98)10532-9
doi: 10.1016/S0140-6736(98)10532-9
Pamidi S, Kimoff RJ. Maternal sleep-disordered breathing. Chest 2018;153:1052–66. doi: 10.1016/j.chest.2017.10.011
doi: 10.1016/j.chest.2017.10.011
Blyton DM, Skilton MR, Edwards N, Hennessy A, Celermajer DS, Sullivan CE. Treatment of sleep disordered breathing reverses low fetal activity levels in preeclampsia. Sleep 2013;36:15–21. doi: 10.5665/sleep.2292
doi: 10.5665/sleep.2292
Blyton DM, Sullivan CE, Edwards N. Reduced nocturnal cardiac output associated with preeclampsia is minimized with the use of nocturnal nasal CPAP. Sleep 2004;27:79–84. doi: 10.1093/sleep/27.1.79
doi: 10.1093/sleep/27.1.79
Chirakalwasan N, Amnakkittikul S, Wanitcharoenkul E, Charoensri S, Saetung S, Chanprasertyothin S, et al. Continuous positive airway pressure therapy in gestational diabetes with obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med 2018;14:327–36. doi: 10.5664/jcsm.6972
doi: 10.5664/jcsm.6972
Stajic D, Ilic D, Vukovic J, Baturan B, Ilic A, Milovancev A. The effect of continuous positive airway pressure treatment on hypertensive disorder in pregnant women with obstructive sleep apnea. Sleep Breath 2022;26:297–305. doi: 10.1007/s11325-021-02397-x
doi: 10.1007/s11325-021-02397-x
Pamidi S, Meltzer SJ, Garfield N, Lavigne L, Olha A, Khalyfa A, et al. A pilot randomized-controlled trial on the effect of CPAP treatment on glycemic control in gestational diabetes: study design and methods. Front Endocrinol (Lausanne) 2018;9:659. doi: 10.3389/fendo.2018.00659
doi: 10.3389/fendo.2018.00659
ClinicalTrials.gov. Continuous positive airway pressure (CPAP) for sleep apnea in pregnancy (SLEEP). Accessed May 1, 2022. https://clinicaltrials.gov/ct2/show/NCT03487185
ClinicalTrials.gov. Positive airway pressure, sleep apnea, and the placenta (PAP-SAP). Accessed May 1, 2022. https://clinicaltrials.gov/ct2/show/NCT02412696
Guilleminault C, Kreutzer M, Chang JL. Pregnancy, sleep disordered breathing and treatment with nasal continuous positive airway pressure. Sleep Med 2004;5:43–51. doi: 10.1016/j.sleep.2003.07.001
doi: 10.1016/j.sleep.2003.07.001
Guilleminault C, Palombini L, Poyares D, Takaoka S, Huynh NTL, El-Sayed Y. Pre-eclampsia and nasal CPAP: part 1. Early intervention with nasal CPAP in pregnant women with risk-factors for pre-eclampsia: preliminary findings. Sleep Med 2007;9:9–14. doi: 10.1016/j.sleep.2007.04.020
doi: 10.1016/j.sleep.2007.04.020
Reid J, Glew RA, Skomro R, Fenton M, Cotton D, Olatunbosun F, et al. Sleep disordered breathing and gestational hypertension: postpartum follow-up study. Sleep 2013;36:717–21B. doi: 10.5665/sleep.2634
doi: 10.5665/sleep.2634
Morong S, Hermsen B, de Vries N. Sleep-disordered breathing in pregnancy: a review of the physiology and potential role for positional therapy. Sleep Breath 2014;18:31–7. doi: 10.1007/s11325-013-0849-9
doi: 10.1007/s11325-013-0849-9
Touil I, Amor HIH, Kechida M, Boudawara NK, Brahem Y, Bouchareb S, et al. Predictive echocardiographic factors of severe obstructive sleep apnea. Pan Afr Med J 2021;38:359. doi: 10.11604/pamj.2021.38.359.28470
doi: 10.11604/pamj.2021.38.359.28470
Lu M, Wang Z, Zhan X, Wei Y. Obstructive sleep apnea increases the risk of cardiovascular damage: a systematic review and meta-analysis of imaging studies. Syst Rev 2021;10:212. doi: 10.1186/s13643-021-01759-6
doi: 10.1186/s13643-021-01759-6
Indications for outpatient antenatal fetal surveillance. ACOG Committee Opinion No. 828. American College of Obstetricians and Gynecologists. Obstet Gynecol 2021;137:e177–97. doi: 10.1097/AOG.0000000000004407
doi: 10.1097/AOG.0000000000004407
Dominguez JE, Krystal AD, Habib AS. Obstructive sleep apnea in pregnant women: a review of pregnancy outcomes and an approach to management. Anesth Analg 2018;127:1167–77. doi: 10.1213/ANE.0000000000003335
doi: 10.1213/ANE.0000000000003335
Louis J, Auckley D, Bolden N. Management of obstructive sleep apnea in pregnant women. Obstet Gynecol 2012;119:864–8. doi: 10.1097/AOG.0b013e31824c0c2f
doi: 10.1097/AOG.0b013e31824c0c2f
Bullough AS. Sleep disordered breathing in pregnancy: an obstetric anesthesiologist's perspective. Open Sleep J 2013;6(suppl 1M6):44–53. doi: 10.2174/1874620901306010044
Booth JM, Tonidandel AM. Peripartum management of obstructive sleep apnea. Clin Obstet Gynecol 2017;60:405–17. doi: 10.1097/GRF.0000000000000279
doi: 10.1097/GRF.0000000000000279
Practice guidelines for the perioperative management of patients with obstructive sleep apnea: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2014;120:268–86. 10.1097/ALN.0000000000000053
doi: 10.1097/ALN.0000000000000053
Sedov ID, Anderson NJ, Dhillon AK, Tomfohr-Madsen LM. Insomnia symptoms during pregnancy: a meta-analysis. J Sleep Res 2020;30:e13207. doi: 10.1111/jsr.13207
doi: 10.1111/jsr.13207
Sivertsen B, Hysing M, Dørheim SK, Eberhard-Gran M. Trajectories of maternal sleep problems before and after childbirth: a longitudinal population-based study. BMC Pregnancy Childbirth 2015;15:129. doi: 10.1186/s12884-015-0577-1
doi: 10.1186/s12884-015-0577-1
Okun ML, Mancuso RA, Hobel CJ, Schetter CD, Coussons-Read M. Poor sleep quality increases symptoms of depression and anxiety in postpartum women. J Behav Med 2018;41:703–10. doi: 10.1007/s10865-018-9950-7
doi: 10.1007/s10865-018-9950-7
Perlis ML, Ellis JG, Kloss JD, Riemann DW. Chapter 82 - etiology and pathophysiology of insomnia. In: Kryger M, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 6th ed. Elsevier; 2017.
Facco FL, Grobman WA, Kramer J, Ho KH, Zee PC. Self-reported short sleep duration and frequent snoring in pregnancy: impact on glucose metabolism. Am J Obstet Gynecol 2010;203:142.e1–5. doi: 10.1016/j.ajog.2010.03.041
doi: 10.1016/j.ajog.2010.03.041
Zhang X, Zhang R, Cheng L, Wang Y, Ding X, Fu J, et al. The effect of sleep impairment on gestational diabetes mellitus: a systematic review and meta-analysis of cohort studies. Sleep Med 2020;74:267–77. doi: 10.1016/j.sleep.2020.05.014
doi: 10.1016/j.sleep.2020.05.014
Emamian F, Khazaie H, Okun ML, Tahmasian M, Sepehry AA. Link between insomnia and perinatal depressive symptoms: a meta-analysis. J Sleep Res 2019;28:e12858. doi: 10.1111/jsr.12858
doi: 10.1111/jsr.12858
Osnes RS, Eberhard-Gran M, Follestad T, Kallestad H, Morken G, Roaldset JO. Mid-pregnancy insomnia is associated with concurrent and postpartum maternal anxiety and obsessive-compulsive symptoms: a prospective cohort study. J Affect Disord 2020;266:319–26. doi: 10.1016/j.jad.2020.01.140
doi: 10.1016/j.jad.2020.01.140
Stern RA, Robinson B, Thorner AR, Arruda JE, Prohaska ML, Prange AJ Jr. A survey study of neuropsychiatric complaints in patients with Graves' disease. J Neuropsychiatry Clin Neurosci 1996;8:181–5. doi: 10.1176/jnp.8.2.181
doi: 10.1176/jnp.8.2.181
Sridhar GR, Putcha V, Lakshmi G. Sleep in thyrotoxicosis. Indian J Endocrinol Metab 2011;15:23–6. doi: 10.4103/2230-8210.77578
doi: 10.4103/2230-8210.77578
Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med 2017;13:307–49. doi: 10.5664/jcsm.6470
doi: 10.5664/jcsm.6470
Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;165:125–33. doi: 10.7326/M15-2175
doi: 10.7326/M15-2175
Manber R, Bei B, Simpson N, Asarnow L, Rangel E, Sit A, et al. Cognitive behavioral therapy for prenatal insomnia: a randomized controlled trial. Obstet Gynecol 2019;133:911–9. doi: 10.1097/AOG.0000000000003216
doi: 10.1097/AOG.0000000000003216
Gehrman P, Gunter P, Findley J, Frasso R, Weljie AM, Kuna ST, et al. Randomized noninferiority trial of telehealth delivery of cognitive behavioral treatment of insomnia compared to in-person care. J Clin Psychiatry 2021:20m13723. doi: 10.4088/JCP.20m13723
doi: 10.4088/JCP.20m13723
Arnedt JT, Conroy DA, Mooney A, Furgal A, Sen A, Eisenberg D. Telemedicine versus face-to-face delivery of cognitive behavioral therapy for insomnia: a randomized controlled noninferiority trial. Sleep 2021;44:zsaa136. doi: 10.1093/sleep/zsaa136
doi: 10.1093/sleep/zsaa136
Kalmbach DA, Cheng P, O'Brien LM, Swanson LM, Sangha R, Sen S, et al. A randomized controlled trial of digital cognitive behavioral therapy for insomnia in pregnant women. Sleep Med 2020;72:82–92. doi: 10.1016/j.sleep.2020.03.016
doi: 10.1016/j.sleep.2020.03.016
Felder JN, Epel ES, Neuhaus J, Krystal AD, Prather AA. Efficacy of digital cognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a randomized clinical trial. JAMA Psychiatry 2020;77:484–92. doi: 10.1001/jamapsychiatry.2019.4491
doi: 10.1001/jamapsychiatry.2019.4491
Felder JN, Epel ES, Neuhaus J, Krystal AD, Prather AA. Randomized controlled trial of digital cognitive behavior therapy for prenatal insomnia symptoms: effects on postpartum insomnia and mental health. Sleep 2022;45:zsab280. doi: 10.1093/sleep/zsab280
doi: 10.1093/sleep/zsab280
Ritterband LM, Thorndike FP, Ingersoll KS, Lord HR, Gonder-Frederick L, Frederick C, et al. Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trial. JAMA Psychiatry 2017;74:68–75. doi: 10.1001/jamapsychiatry.2016.3249
doi: 10.1001/jamapsychiatry.2016.3249
Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 2012;35:769–81. doi: 10.5665/sleep.1872
doi: 10.5665/sleep.1872
Erten Uyumaz B, Feijs L, Hu J. A review of digital cognitive behavioral therapy for insomnia (Cbt-i apps): are they designed for engagement? Int J Environ Res Public Health 2021;18:2929–16. doi: 10.3390/ijerph18062929
doi: 10.3390/ijerph18062929
MacKinnon AL, Madsen JW, Dhillon A, Keys E, Giesbrecht GF, Williamson T, et al. Sleeping for two: study protocol for a randomized controlled trial of cognitive behavioral therapy for insomnia in pregnant women. Trials 2021;22:532. doi: 10.1186/s13063-021-05498-w
doi: 10.1186/s13063-021-05498-w
Hipson WE, Fisher DJ. The association between acute stress-related insomnia and alcohol use. Sleep Health 2016;2:246–52. doi: 10.1016/j.sleh.2016.06.002
doi: 10.1016/j.sleh.2016.06.002
Sjoqvist F, Lasagna L. The hypnotic efficacy of doxylamine. Clin Pharmacol Ther 1967;8:48–54. doi: 10.1002/cpt196781part148
doi: 10.1002/cpt196781part148
Li Q, Mitchell AA, Werler MM, Yau WP, Hernandez-Diaz S. Assessment of antihistamine use in early pregnancy and birth defects. J Allergy Clin Immunol Pract 2013;1:666–74. doi: 10.1016/j.jaip.2013.07.008
doi: 10.1016/j.jaip.2013.07.008
Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, et al. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep 2011;34:1433–42. doi: 10.5665/SLEEP.1294
doi: 10.5665/SLEEP.1294
McElhatton PR, Garbis HM, Elefant E, Vial T, Bellemin B, Mastroiacovo P, et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 1996;10:285–94. doi: 10.1016/0890-6238(96)00057-3
doi: 10.1016/0890-6238(96)00057-3
Wang LH, Lin HC, Lin CC, Chen YH, Lin HC. Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. Clin Pharmacol Ther 2010;88:369–74. doi: 10.1038/clpt.2010.97
doi: 10.1038/clpt.2010.97
Juric S, Newport DJ, Ritchie JC, Galanti M, Stowe ZN. Zolpidem (Ambien) in pregnancy: placental passage and outcome. Arch Womens Ment Health 2009;12:441–6. doi: 10.1007/s00737-009-0100-7
doi: 10.1007/s00737-009-0100-7
Wikner BN, Kallen B. Are hypnotic benzodiazepine receptor agonists teratogenic in humans? J Clin Psychopharmacol 2011;31:356–9. doi: 10.1097/JCP.0b013e3182197055
doi: 10.1097/JCP.0b013e3182197055
Matheson I, Pande H, Alertsen AR. Respiratory depression caused by N-desmethyldoxepin in breast milk. Lancet 1985;2:1124. doi: 10.1016/s0140-6736(85)90712-3
doi: 10.1016/s0140-6736(85)90712-3
Kemp J, Ilett KF, Booth J, Hackett LP. Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol 1985;20:497–9. doi: 10.1111/j.1365-2125.1985.tb05106.x
doi: 10.1111/j.1365-2125.1985.tb05106.x
Pons G, Francoual C, Guillet P, Moran C, Hermann P, Bianchetti G, et al. Zolpidem excretion in breast milk. Eur J Clin Pharmacol 1989;37:245–8. doi: 10.1007/BF00679778
doi: 10.1007/BF00679778
Cain MA, Brumley J, Louis-Jacques A, Drerup M, Stern M, Louis JM. A pilot study of a sleep intervention delivered through group prenatal care to overweight and obese women. Behav Sleep Med 2020;18:477–87. doi: 10.1080/15402002.2019.1613995
doi: 10.1080/15402002.2019.1613995
Felder JN, Epel ES, Neuhaus J, Krystal AD, Prather AA. Efficacy of digital cognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a randomized clinical trial. JAMA Psychiatry 2020;77:484–92. doi: 10.1001/jamapsychiatry.2019.4491
doi: 10.1001/jamapsychiatry.2019.4491
Bacaro V, Benz F, Pappaccogli A, De Bartolo P, Johann AF, Palagini L, et al. Interventions for sleep problems during pregnancy: a systematic review. Sleep Med Rev 2020;50:101234. doi: 10.1016/j.smrv.2019.101234
doi: 10.1016/j.smrv.2019.101234
Irwin MR, Carrillo C, Sadeghi N, Bjurstrom MF, Breen EC, Olmstead R. Prevention of incident and recurrent major depression in older adults with insomnia: a randomized clinical trial. JAMA Psychiatry 2022;79:33–41. doi: 10.1001/jamapsychiatry.2021.3422
doi: 10.1001/jamapsychiatry.2021.3422
Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005;14:43–7. doi: 10.1111/j.1365-2869.2004.00403.x
doi: 10.1111/j.1365-2869.2004.00403.x
Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165:1286–92. doi: 10.1001/archinte.165.11.1286
doi: 10.1001/archinte.165.11.1286
Manconi M, Govoni V, De Vito A, Economou NT, Cesnik E, Casetta I, et al. Restless legs syndrome and pregnancy. Neurology 2004;63:1065–9. doi: 10.1212/01.wnl.0000138427.83574.a6
doi: 10.1212/01.wnl.0000138427.83574.a6
Pantaleo NP, Hening WA, Allen RP, Earley CJ. Pregnancy accounts for most of the gender difference in prevalence of familial RLS. Sleep Med 2010;11:310–3. doi: 10.1016/j.sleep.2009.04.005
doi: 10.1016/j.sleep.2009.04.005
Neau J-P, Porcheron A, Mathis S, Julian A, Meurice JC, Paquereau J, et al. Restless legs syndrome and pregnancy: a questionnaire study in the Poitiers district, France. Eur Neurol 2010;64:268–74. doi: 10.1159/000321413
doi: 10.1159/000321413
Chen SJ, Shi L, Bao YP, Sun YK, Lin X, Que JY, et al. Prevalence of restless legs syndrome during pregnancy: a systematic review and meta-analysis. Sleep Med Rev 2018;40:43–54. doi: 10.1016/j.smrv.2017.10.003
doi: 10.1016/j.smrv.2017.10.003
Hübner A, Krafft A, Gadient S, Werth E, Zimmermann R, Bassetti CL. Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study. Neurology 2013;80:738–42. doi: 10.1212/WNL.0b013e318283baf3
doi: 10.1212/WNL.0b013e318283baf3
Goodman JDSB C, Brodie C, Pearce JMA GA, Ayida GA. Restless leg syndrome in pregnancy. BMJ 1988;297:1101–2. doi: 10.1136/bmj.297.6656.1101-a
doi: 10.1136/bmj.297.6656.1101-a
Tunç T, Karadağ YS, Doğulu F, Inan LE. Predisposing factors of restless legs syndrome in pregnancy. Mov Disord 2007;22:627–31. doi: 10.1002/mds.21291
doi: 10.1002/mds.21291
Steinweg K, Nippita T, Cistulli PA, Bin YS. Maternal and neonatal outcomes associated with restless legs syndrome in pregnancy: a systematic review. Sleep Med Rev 2020;54:101359. doi: 10.1016/j.smrv.2020.101359
doi: 10.1016/j.smrv.2020.101359
Allen RP, Burchell BJ, MacDonald B, Hening WA, Earley CJ. Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey. Sleep Med 2009;10:1097–100. doi: 10.1016/j.sleep.2008.10.007
doi: 10.1016/j.sleep.2008.10.007
Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E, Agundez JAG. Association between restless legs syndrome and peripheral neuropathy: a systematic review and meta-analysis. Eur J Neurol 2021;28:2423–42. doi: 10.1111/ene.14840
doi: 10.1111/ene.14840
Innes KE, Selfe TK, Montgomery C, Hollingshead N, Huysmans Z, Srinivasan R, et al. Effects of a 12-week yoga versus a 12-week educational film intervention on symptoms of restless legs syndrome and related outcomes: an exploratory randomized controlled trial. J Clin Sleep Med 2020;16:107–19. doi: 10.5664/jcsm.8134
doi: 10.5664/jcsm.8134
Jafarimanesh H, Vakilian K, Mobasseri S. Thermo-therapy and cryotherapy to decrease the symptoms of restless leg syndrome during the pregnancy: a randomized clinical trial. Complement Ther Med 2020;50:102409. doi: 10.1016/j.ctim.2020.102409
doi: 10.1016/j.ctim.2020.102409
Lettieri CJ, Eliasson AH. Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial. Chest 2009;135:74–80. doi: 10.1378/chest.08-1665
doi: 10.1378/chest.08-1665
Silber MH, Buchfuhrer MJ, Earley CJ, Koo BB, Manconi M, Winkelman JW, et al. The management of restless legs syndrome: an updated algorithm. Mayo Clinic Proc 2021;96:1921–37. doi: 10.1016/j.mayocp.2020.12.026
doi: 10.1016/j.mayocp.2020.12.026
Dostal M, Weber-Schoendorfer C, Sobesky J, Schaefer C. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series. Eur J Neurol 2013;20:1241–6. doi: 10.1111/ene.12001
doi: 10.1111/ene.12001
Zlotnik Y, Giladi N, Hilel A, Shapira Y, Goldstein S, Gurevich T. Levodopa-carbidopa intestinal gel (LCIG) infusion during pregnancy and delivery: first documented case. Parkinsonism Relat Disord 2014;20:1317–8. doi: 10.1016/j.parkreldis.2014.09.018
doi: 10.1016/j.parkreldis.2014.09.018
Hagell P, Odin P, Vinge E. Pregnancy in Parkinson's disease: a review of the literature and a case report. Mov Disord 1998;13:34–8. doi: 10.1002/mds.870130110
doi: 10.1002/mds.870130110
Gabapentin. Reprotox 2021.
Veroniki AA, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med 2017;15:95–20. doi: 10.1186/s12916-017-0845-1
doi: 10.1186/s12916-017-0845-1
Weston J, Bromley R, Jackson CF, Adab N, Clayton-Smith J, Greenhalgh J, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. The Cochrane Database of Systematic Reviews 2016, Issue 11. Art. No.: CD010224. doi: 10.1002/14651858.CD010224.pub2
Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011;204:314.e1–11. doi: 10.1016/j.ajog.2010.12.039
doi: 10.1016/j.ajog.2010.12.039
Bloor M, Paech MJ, Kaye R. Tramadol in pregnancy and lactation. Int J Obstet Anesth 2012;21:163–7. doi: 10.1016/j.ijoa.2011.10.008
doi: 10.1016/j.ijoa.2011.10.008
Picchietti DL, Hensley JG, Bainbridge JL, Lee KA, Manconi M, McGregor JA, et al. Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation. Sleep Med Rev 2015;22:64–77. doi: 10.1016/j.smrv.2014.10.009
doi: 10.1016/j.smrv.2014.10.009
Low TL, Choo FN, Tan SM. The efficacy of melatonin and melatonin agonists in insomnia - an umbrella review. J Psychiatr Res 2020;121:10–23. doi: 10.1016/j.jpsychires.2019.10.022
doi: 10.1016/j.jpsychires.2019.10.022
Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med 2017;13:307–49. doi: 10.5664/jcsm.6470
doi: 10.5664/jcsm.6470
Hobson SR, Gurusinghe S, Lim R, Alers NO, Miller SL, Kingdom JC, et al. Melatonin improves endothelial function in vitro and prolongs pregnancy in women with early-onset preeclampsia. J Pineal Res 2018;65:e12508. doi: 10.1111/jpi.12508
doi: 10.1111/jpi.12508
Miller SL, Yawno T, Alers NO, Castillo-Melendez M, Supramaniam VG, VanZyl N, et al. Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction. J Pineal Res 2014;56:283–94. doi: 10.1111/jpi.12121
doi: 10.1111/jpi.12121
Saito J, Tachibana Y, Sano Wada Y, Kawasaki H, Miura Y, Oho M, et al. Presence of hypnotics in the cord blood and breast milk, with No adverse effects in the infant: a case report. Breastfeed Med 2022;17:349–52. doi: 10.1089/bfm.2021.0321
doi: 10.1089/bfm.2021.0321
Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993;168:1393–9. doi: 10.1016/s0002-9378(11)90771-6
doi: 10.1016/s0002-9378(11)90771-6
Ngo E, Spigset O, Lupattelli A, Panchaud A, Annaert P, Allegaert K, et al. Antihistamine use during breastfeeding with focus on breast milk transfer and safety in humans: a systematic literature review. Basic Clin Pharmacol Toxicol 2022;130:171–81. doi: 10.1111/bcpt.13663
doi: 10.1111/bcpt.13663
Anderson PO. Respiratory drugs during breastfeeding. Breastfeed Med 2019;14:613–15. doi: 10.1089/bfm.2019.0194
doi: 10.1089/bfm.2019.0194
Frey OR, Scheidt P, von Brenndorff AI. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother 1999;33:690–3. doi: 10.1345/aph.18210
doi: 10.1345/aph.18210
American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776–89. doi: 10.1542/peds.108.3.776
doi: 10.1542/peds.108.3.776
Sheehy O, Zhao JP, Berard A. Association between incident exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion. JAMA Psychiatry 2019;76:948–57. doi: 10.1001/jamapsychiatry.2019.0963
doi: 10.1001/jamapsychiatry.2019.0963
Wang X, Zhang T, Ekheden I, Chang Z, Hellner C, Jan Hasselstrom, et al. Prenatal exposure to benzodiazepines and Z-drugs in humans and risk of adverse neurodevelopmental outcomes in offspring: a systematic review. Neurosci Biobehav Rev 2022;137:104647. doi: 10.1016/j.neubiorev.2022.104647
doi: 10.1016/j.neubiorev.2022.104647
Jensen AG, Knudsen SS, Bech BH. Prenatal exposure to benzodiazepines and the development of the offspring - a systematic review. Neurotoxicol Teratol 2022;91:107078. doi: 10.1016/j.ntt.2022.107078
doi: 10.1016/j.ntt.2022.107078
Kelly LE, Poon S, Madadi P, Koren G. Neonatal benzodiazepines exposure during breastfeeding. J Pediatr 2012;161:448–51. doi: 10.1016/j.jpeds.2012.03.003
doi: 10.1016/j.jpeds.2012.03.003
Ban L, West J, Gibson JE, Fiaschi L, Sokal R, Doyle P, et al. First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study. PLoS One 2014;9:e100996. doi: 10.1371/journal.pone.0100996
doi: 10.1371/journal.pone.0100996
Xue T, Wu X, Chen S, Yang Y, Yan Z, Song Z, et al. The efficacy and safety of dual orexin receptor antagonists in primary insomnia: a systematic review and network meta-analysis. Sleep Med Rev 2022;61:101573. doi: 10.1016/j.smrv.2021.101573
doi: 10.1016/j.smrv.2021.101573